SPECTRANETICS CORPORATION TIGHTRAIL SUB-C ROTATING DILATOR SHEATH; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
|
Back to Search Results |
|
Model Number 560-011 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/10/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
A2): patient''s date of birth, age unk h3): the device was discarded, thus no investigation could be completed.H6): the cause of the tightrail sub-c likely cutting the lv lead/lld could not be established.Submission of this report does not, in itself, represent a conclusion by the manufacturer and/or authorized representative or the national competent authority that the content of this report is complete or accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or contributed to an alleged death or deterioration in the state of the health of any person.
|
|
Event Description
|
A lead extraction procedure commenced to remove a right ventricular (rv) and a left ventricular (lv) lead due to lead fracture.A right atrial (ra) lead was present in the patient as well, but was not initially targeted for extraction.Spectranetics lld ez lead locking devices (lld ezs) were inserted into the rv and lv leads to provide traction.Beginning with a spectranetics 11f tightrail sub-c rotating dilator sheath on the lv lead, it appeared the tightrail cut the lv lead and lld in the subclavian region.Switching efforts to the rv lead, multiple spectranetics devices were used (glidelight laser sheath, visisheath dilator sheath, tightrail (long) rotating dilator sheath) to attempt removal, but were unsuccessful.It was determined the ra lead required removal, due to lead on lead binding to the rv and lv leads.An lld ez was inserted into the ra lead to provide traction, and multiple devices were used to achieve successful removal of the lead.Then, switching efforts to the rv lead again, lead removal was achieved.Removal of the lv lead/lld remnants was not attempted, and because the lld was likely cut by the tightrail sub-c, it could not be unlocked from the lv lead.The lv lead/lld were capped and remained in the patient (mdr #3007284006-2024-00021).The patient survived the procedure.This report captures the 11f tightrail sub-c which likely cut the lv lead/lld in the procedure.There was no alleged malfunction of any spectranetics devices in use during the procedure.
|
|
Manufacturer Narrative
|
There was no adverse event.The tightrail sub-c did not malfunction during the procedure.However, it likely cut the lv lead/lld which can result in potential for harm with recurrence.Corrected from adverse event to product problem.Corrected reference mdr # from 3007284006-2024-00021 to 3007284006-2024-00023.Corrected from serious injury to malfunction.Submission of this report does not, in itself, represent a conclusion by the manufacturer and/or authorized representative or the national competent authority that the content of this report is complete or accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or contributed to an alleged death or deterioration in the state of the health of any person.
|
|
Event Description
|
A lead extraction procedure commenced to remove a right ventricular (rv) and a left ventricular (lv) lead due to lead fracture.A right atrial (ra) lead was present in the patient as well, but was not initially targeted for extraction.Spectranetics lld ez lead locking devices (lld ezs) were inserted into the rv and lv leads to provide traction.Beginning with a spectranetics 11f tightrail sub-c rotating dilator sheath on the lv lead, it appeared the tightrail cut the lv lead and lld in the subclavian region (mdr #3007284006-2024-00022).Switching efforts to the rv lead, multiple spectranetics devices were used (glidelight laser sheath, visisheath dilator sheath, tightrail (long) rotating dilator sheath) to attempt removal, but were unsuccessful.It was determined the ra lead required removal, due to lead on lead binding to the rv and lv leads.An lld ez was inserted into the ra lead to provide traction, and multiple devices were used to achieve successful removal of the lead.Then, switching efforts to the rv lead again, lead removal was achieved.Removal of the lv lead/lld remnants was not attempted, and because the lld was likely cut by the tightrail sub-c, it could not be unlocked from the lv lead.The lv lead/lld were capped and remained in the patient (mdr #3007284006-2024-00023).The patient survived the procedure.This event is being reported in an abundance of caution to capture the 11f tightrail sub-c which likely cut the lv lead/lld in the procedure, potential for harm.There was no alleged malfunction of this tightrail sub-c or any spectranetics devices in use during the procedure.
|
|
Search Alerts/Recalls
|
|
|